Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Apr-Jun;12(2):168-171.
doi: 10.4103/jpn.JPN_12_17.

Rosette-forming Glioneuronal Tumor: A Rare Posterior Fossa Tumor in an Adolescent

Affiliations
Case Reports

Rosette-forming Glioneuronal Tumor: A Rare Posterior Fossa Tumor in an Adolescent

Goutam Bera et al. J Pediatr Neurosci. 2017 Apr-Jun.

Abstract

Rosette-forming glioneuronal tumor (RGNT) is a rare variety of slow growing mixed glioneuronal tumor involving primarily fourth ventricular region and occurring predominantly in young adults. We present a case of a 16-year-old boy who presented with dizziness and occipital headache. On radiological evaluation, a fairly large hypodense posterior fossa mass lesion in relation to the left side of the vermis, with a large cystic component was found. Surgical resection of the tumor was performed. Histopathological examination showed a biphasic tumor composed of bland neurocytic cells, arranged in the form of neurocytic rosettes along with glial areas resembling low-grade glioma. The neurocytic rich region shows strong synaptophysin positivity in the neuropil-rich core of the rosettes. Methylation-inhibited binding proliferative index was low (<1%). Based on these features, a diagnosis of RGNT was made. RGNT of the fourth ventricle should be considered in differential diagnosis of posterior fossa lesions, especially in relation to fourth ventricle and vermis in young adults.

Keywords: Adolescent; brain tumors; rosette-forming glioneuronal tumor.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Preoperative gadolinium-enhanced T1 axial image showing partly solid and partly cystic tumor
Figure 2
Figure 2
(a) Low power view showing rosettes lined by a single layer of bland neurocytic cells. (b) High power view of the neurocytic rosette. (c) Immunohistochemistry for synaptophysin highlights the neuropil-rich core of the rosette. The inset shows high power view of the same. (d) The rosettes are negative for glial fibrillary acidic protein immunostain
Figure 3
Figure 3
One-year postoperative, gadolinium-enhanced T1 axial image, showing complete removal of tumor

Similar articles

Cited by

References

    1. Kuchelmeister K, Demirel T, Schlörer E, Bergmann M, Gullotta F. Dysembryoplastic neuroepithelial tumour of the cerebellum. Acta Neuropathol. 1995;89:385–90. - PubMed
    1. Komori T, Scheithauer BW, Hirose T. A rosette-forming glioneuronal tumor of the fourth ventricle: Infratentorial form of dysembryoplastic neuroepithelial tumor? Am J Surg Pathol. 2002;26:582–91. - PubMed
    1. Hainfellner JA, Scheithauer BW, Giangaspero F, Rosenblum MK. WHO Classification of Tumours of the Central Nervous System. 4th ed. Lyon: IARC Press; 2007. Rosette forming glioneuronal tumour of the fourth ventricle; pp. 115–6.
    1. Arai A, Sasayama T, Tamaki M, Sakagami Y, Enoki E, Ohbayashi C, et al. Rosette-forming glioneuronal tumor of the fourth ventricle – Case report. Neurol Med Chir (Tokyo) 2010;50:224–8. - PubMed
    1. Solis OE, Mehta RI, Lai A, Mehta RI, Farchoukh LO, Green RM, et al. Rosette-forming glioneuronal tumor: A pineal region case with IDH1 and IDH2 mutation analyses and literature review of 43 cases. J Neurooncol. 2011;102:477–84. - PMC - PubMed

Publication types